Evidence map›Paper›PMID 18607776›Full record

ArticleJournal of molecular neuroscience : MN2008

VIP, from gene to behavior and back: summarizing my 25 years of research.

Illana Gozes

Abstract readHistorical Article
PubMed Publisher
In one paragraph

Article in Journal of molecular neuroscience : MN, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. mTOR signaling in VIP neurons regulates circadian clock synchrony and olfaction.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Illana GozesAdams Super Center for Brain Studies, The Dr. Diana and Zelman Elton Elbaum Laboratory for Molecular Neuroendocrinology, Department of Human Molecular Genetics and Biochemistry, Tel Aviv University, Tel Aviv, Israel. igozes@post.tau.ac.il
Tel Aviv University · IL

Funding

Intramural NIH HHS
6 · The paper itself

Abstract

Vasoactive intestinal peptide (VIP) is an interesting example of a 28-amino acid neuropeptide that is abundantly expressed in discrete brain regions/neurons and hence may contribute to brain function. This short review summarizes my own point of view and encompasses 25 years of work and over 100 publications targeting the understanding of VIP production and biological activity. The review starts with our original cloning of the VIP gene, it then continues to discoveries of regulation of VIP synthesis and the establishment of the first VIP transgenic mice. The review ends with the identification of novel VIP analogs that helped decipher VIP's important role during development, in regulation of the biological clock(s) and diurnal rhythms, sexual activity, learning and memory as well as social behavior, and cancer. This review cites only articles that I have coauthored and gives my own perspective of this exciting ever-growing field.

Indexed as

ResearchVasoactive Intestinal PeptideAmino Acid SequenceAnimalsBiological ClocksBrainCell ProliferationCyclic AMPCytokinesHistory, 20th CenturyHistory, 21st CenturyHumansIntercellular Signaling Peptides and ProteinsMolecular Sequence DataNeoplasmsRNA, MessengerCyclic AMPCytokinesIntercellular Signaling Peptides and ProteinsRNA, MessengerVasoactive Intestinal Peptide

Identifiers

PMID18607776
OpenAlexW2054752096

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.